News
ARFID or reasonable food restriction? The jury is out
Don’t jump to conclusions about avoidant restrictive food intake disorder in patients with gastrointestinal diseases, psychologists advise.
News
Monotherapy or one-two punch against EGFR-mutant NSCLC?
Clinicians debate whether combining other drugs with osimertinib adds anything but toxicity to the care of patients with EGFR-mutated NSCLC.
News
DKMS: Small nonprofit to world’s largest stem cell donor registry
A German family’s tragedy launched DKMS, a multinational organization whose goal is to “delete blood cancer.”
News
TKI/BiTE combo extends survival of older patients with Ph+ALL
In these elderly patients who are not candidates for chemo, the issue is whether we can prolong remission by the addition of other treatments,...
News
Adaptive therapy borrows from nature to keep rhabdomyosarcoma in check
Researchers are applying evolutionary principles to the treatment of childhood, fusion-positive rhabdomyosarcoma.
News
AGILE: ‘Exciting’ survival results for IDH1-mutated AML
Results show survival that is three times longer for a combination of ivosidenib plus azacitidine versus azacitidine alone in a distinct...
News
Isatuximab added to RVd boosts response in new myeloma
A drug approved in 2020 for treatment of advanced multiple myeloma has been shown to benefit patients newly diagnosed with the disease.
News
‘Outstanding data’: Mosunetuzumab in r/r follicular lymphoma
If approved by the FDA, mosunetuzumab has the potential to be a first-in-class CD20xCD3 T-cell engaging bispecific antibody in non-Hodgkin...
News
‘Remarkable’ results with CAR T cells could make chemo obsolete
“It’s really remarkable that the results are so far in favor of the CAR T-cell therapy that I think it’s inevitable that this will become the...
News
Liver cancer risk lingers even after HCV eradication
Not having a sustained viral response was associated with a more than sevenfold higher risk for liver cancer in a multicenter study.
News
ASH meeting: Diversity, inclusion, immunotherapy, and COVID-19
“While there have been many advances in the treatment of acute myeloid leukemia ... addressing end-of-life issues is an often neglected area.”
News
NAFLD, ALD prevalent among teens, young adults
It’s important to “mitigate modifiable risk factors to prevent disease development and disease progression to potentially advanced fibrosis and...
News
In pill or food form, healthy fatty acids reduce liver fat
For patients with NAFLD who supplement their diets with polyunsaturated fatty acids, liver and metabolic parameters improve, results of a...
News
Immunotherapies for children with r/r ALL face off
Outcomes were better with tisagenlecleucel vs. blinatumomab in an indirect comparison, but clinical indications should determine which agent to...
News
Adding rituximab to belimumab offers no help for lupus
The combination of rituximab and belimumab was associated with a longer duration of response, but there was no benefit of belimumab alone for...